Nucleati

Physicians rely on the latest, high-quality evidence to tailor patient care. However, accessing such data can be challenging, necessitating high-quality, reliable, transparent, unbiased, and updated information. Nucleati utilizes cutting-edge technologies to collect, curate, store, and distribute such medical evidence using fully automated workflows. Among our innovative products are: Adenine AI: AI collected, curated, and updated evidence to assist medical geneticists, molecular pathologists, genetic counselors, and researchers. Nucleati Abstracts: Featuring low latency REST-APIs granting access to over 30 million abstracts from published articles, ideal for language processing tasks. Adverse Drug Reactions Evidence Base: Providing over 35,000 pieces of evidence on adverse effects induced by drugs, drug-drug interactions, and individual genotypes.